Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03414125 · ClinicalTrials.gov registry record · NA
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 26,859
- Enrollment target
NCT03414125: Completed NA study, sponsored by University of Texas Southwestern Medical Center.
NCT03414125 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 26,859 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1814% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03414125, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 26,859 participants
- Enrollment target
Study Summary
This is a pragmatic, randomized, controlled trial comparing whether a mailed outreach intervention offering patients who are not up-to-date with colorectal cancer (CRC) a choice of completing a home Fecal Immunochemical Test (FIT) test or scheduling a screening colonoscopy increases CRC screening completion compared to a mailed FIT kit outreach program (which does not offer an explicit choice of screening modality). The trial will be conducted in a racially and socioeconomically diverse cohort of patients served by an integrated safety net delivery system that has a "FIT first" population health screening strategy. All patients will also have access to whatever CRC screening is recommended through usual visit-based care.
Primary Outcome
Proportion of patients who complete CRC screening with colonoscopy, sigmoidoscopy, or FIT
Interventions
- OTHER FIT Screening Strategy
- OTHER Choice Screening Strategy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26,859 participants |
| Start Date | 2018-09-07 |
| Est. Completion | 2021-08-31 |
| Phase | NA |
What the finished NCT03414125 record still lists
NCT03414125 is an interventional study that assigns participants to a tested intervention. Its 26,859 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1814% higher).
The record links to 0 conditions, and to 2 interventions - of which FIT Screening Strategy is the first listed.
NCT03414125 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03414125 about?
NCT03414125 is a clinical study titled "Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening". This is a pragmatic, randomized, controlled trial comparing whether a mailed outreach intervention offering patients who are not up-to-date with colorectal cancer (CRC) a choice of completing a home Fecal Immunochemical Test (FIT) test or scheduling a screening colonoscopy increases CRC screening co...
What is the current status of trial NCT03414125?
This trial is currently completed. It is a NA study. The enrollment target is 26,859 participants. The study started on 2018-09-07. Estimated completion is 2021-08-31.
What interventions are being tested in trial NCT03414125?
The interventions under investigation include: FIT Screening Strategy (OTHER), Choice Screening Strategy (OTHER).
Who is sponsoring clinical trial NCT03414125?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03414125's enrollment target sits among peer trials
26,859 9th of 2000 higher than 1,992 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04678193 · 27,000 participants
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
- NCT04494945 · 27,500 participants · NA
Identifying and Caring for Individuals With Inherited Cancer Syndrome
- NCT07300839 · 25,500 participants · Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
- NCT03175302 · 25,240 participants
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI